Abrehet Abdu

This inventor holds 16 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Nucleotide Engineering. Top assignee: Singular Genomics Systems, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abrehet Abdu. Retrieved from https://idiyas.com/inventor/abrehet-abdu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 8)

% Patents Active = 93.8

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 115(Granted Patents)

Location History:

San Diego, CA (US) (2020 - 2024)
La Jolla, CA (US) (2024)

Company Filing History:

16 out of 139

Singular Genomics Systems, Inc.

patents

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

Strand Displacing Amplification Enzymes

Dark Cycle Sequencing

Engineered Enzymes

Nucleotide Analogues

Long Read Sequencing

Modified Pyrococcus Polymerases

Nucleotide Impurities

Methods for Sequencing

Compositions for Reducing Impurities

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12668834 - STRAND DISPLACING AMPLIFICATION ENZYMES (2026-06-30),

2. 12404550 - Dark cycle sequencing (2025-09-02),

3. 12344867 - Engineeredenzymes and uses thereof (2025-07-01),

4. 12215122 - Nucleotide analogues (2025-02-04),

5. 12145960 - Nucleotide analogues (2024-11-19),

6. 12123054 - Methods for long read sequencing (2024-10-22),

7. 12116629 - Methods and compositions for reducing nucleotide impurities (2024-10-15),

8. 12031179 - Methods and compositions for reducing nucleotide impurities (2024-07-09),

9. 11958877 - Nucleotide analogues (2024-04-16),

10. 11891633 - Modified pyrococcus polymerases and uses thereof (2024-02-06),

11. 11884943 - Engineeredenzymes and uses thereof (2024-01-30),

12. 11878993 - Nucleotide analogues (2024-01-23),

13. 11851687 - Modifiedpolymerases and uses thereof (2023-12-26),

14. 11225688 - Methods for long read sequencing (2022-01-18),

15. 11034942 - Modified pyrococcus polymerases and uses thereof (2021-06-15),

Title: The Innovative Contributions of Abrehet Abdu

Introduction: Abrehet Abdu is a prominent inventor based in San Diego, California, recognized for his significant contributions in the field of molecular biology. With a remarkable portfolio of 13 patents, he continues to push the boundaries of innovation in genetic research and sequencing technologies.

Latest Patents: Among his latest innovations are groundbreaking patents related to nucleotide analogues. These patents disclose various compounds, compositions, and methods that are instrumental in the sequencing of nucleic acids. His work on nucleotide analogues represents a critical advancement in the capabilities of genetic sequencing techniques, offering new possibilities for research and application.

Career Highlights: Abrehet Abdu is currently affiliated with Singular Genomics Systems, Inc., a company focused on developing advanced genomic technologies. His work there has solidified his reputation as an industry leader in genomic research and innovation.

Collaborations: Throughout his career, Abrehet has collaborated with several notable researchers, including Eli N. Glezer and Olga Adelfinskaya. These collaborations have allowed for the exchange of ideas and technologies that enhance the scope and impact of their innovative work.

Conclusion: Abrehet Abdu’s contributions to the field of genetic research through his patents and collaborations underline the importance of innovation in advancing scientific understanding. His continued efforts in developing nucleotide analogues pave the way for new discoveries in molecular biology, positioning him as a key figure in the landscape of modern genetic research.

Profile summary based on public USPTO records.